Solvay Cleared From FDA Application Integrity Policy; Luvox Decision Pending
Executive Summary
Solvay has been cleared from FDA's Application Integrity Policy list as of April 9
You may also be interested in...
Solvay Picks Up Tricor Franchise Through Acquisition Of Fournier Pharma
Solvay plans to continue working with Abbott on the Tricor franchise in the U.S. after acquiring Fournier Pharma
Solvay Picks Up Tricor Franchise Through Acquisition Of Fournier Pharma
Solvay plans to continue working with Abbott on the Tricor franchise in the U.S. after acquiring Fournier Pharma
Solvay Estratest Female Sexual Dysfunction Studies Could Save Product – FDA
Solvay should provide studies supporting the use of Estratest (estrogen/methyltestosterone) for the treatment of female sexual dysfunction to keep the product on the market, FDA suggests